Aaron Michael Bartek , APRN
Nurse Practitioner • Wahoo, NE
1760 County Road J
Wahoo, NE 680664152
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 31, 2018; this date does not establish years in practice.
-
Published CMS data list 910 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Baclofen — 101 prescription fills, including refills.
- Gabapentin — 67 prescription fills, including refills.
- Teriflunomide — 67 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 33 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Nebraska (2024, 499 clinicians with data). Median for this group: 240. Middle half: 71 to 871.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 303 in 2020 to 910 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
1760 County Road J
Wahoo, NE 680664152
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,225 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,454,816 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $3,826.01 across 98 records.
By nature of payment
- Food and Beverage: $2,191.01 across 95 records.
- Consulting Fee: $1,635.00 across 3 records.
Reporting-company totals (3 largest of 20)
- TG Therapeutics, Inc.: $2,101.94 across 16 records.
- Biogen, Inc.: $372.07 across 12 records.
- Novartis Pharmaceuticals Corporation: $237.49 across 17 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2018
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Aaron Bartek has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Aaron Bartek as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Wahoo and Nebraska
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Nebraska (2024, 499 clinicians with data). Median for this group: 240. Middle half: 71 to 871.
Too few clinicians listed under Nurse Practitioner in Wahoo have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner in Nebraska (2024, 499 clinicians with data). Median for this group: $11,995. Middle half: $823 to $90,248.
Too few clinicians listed under Nurse Practitioner in Wahoo have Medicare Part D data for 2024 to compare.
4 active clinicians are listed under Nurse Practitioner with a practice address in Wahoo, NE (987 in Nebraska).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 200% from 303 in 2020 to 910 in 2024.
- 2020: 303
- 2021: 407
- 2022: 719
- 2023: 821
- 2024: 910
-
30-day fills
30-day fills increased 280% from 322 in 2020 to 1,225 in 2024.
- 2020: 322
- 2021: 465
- 2022: 876
- 2023: 1,064
- 2024: 1,225
-
Part D drug cost
Part D drug cost increased 9037% from $15,922 in 2020 to $1,454,816 in 2024.
- 2020: $15,922
- 2021: $1,072,150
- 2022: $1,612,506
- 2023: $1,394,030
- 2024: $1,454,816
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 190% from $1,317.20 in 2021 to $3,826.01 in 2025.
- 2021: $1,317.20
- 2022: $1,258.16
- 2023: $2,530.47
- 2024: $1,973.40
- 2025: $3,826.01
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 98 records totaling $3,826.01.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| TG Therapeutics, Inc. |
Consulting Fee
Cash or cash equivalent
|
BRIUMVI | General | $1,080.00 |
| TG Therapeutics, Inc. |
Consulting Fee
Cash or cash equivalent
|
BRIUMVI | General | $405.00 |
| Biogen, Inc. |
Consulting Fee
Cash or cash equivalent
|
TYSABRI | General | $150.00 |
| PIRAMAL CRITICAL CARE |
Food and Beverage
In-kind items and services
|
GABLOFEN | General | $120.14 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $120.14 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $101.96 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $79.19 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $78.76 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $56.82 |
| Biogen, Inc. |
Food and Beverage
In-kind items and services
|
TYSABRI | General | $51.97 |
| EMD Serono, Inc. |
Food and Beverage
Cash or cash equivalent
|
— | General | $44.12 |
| EMD Serono, Inc. |
Food and Beverage
Cash or cash equivalent
|
— | General | $38.98 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
— | General | $38.81 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
SYNCHROMEDII | General | $38.15 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
— | General | $34.59 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $32.00 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
PONVORY | General | $31.71 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Ocrevus Zunovo | General | $30.00 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
PONVORY | General | $29.28 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $28.59 |
| Biogen, Inc. |
Food and Beverage
In-kind items and services
|
TYSABRI | General | $28.31 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
Dysport | General | $27.69 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.57 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $27.22 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $26.37 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Baclofen | Baclofen | 101 | 4,615 | $2,027.78 | 28 |
| Gabapentin | Gabapentin | 67 | 3,463 | $1,120.30 | 14 |
| Teriflunomide | Teriflunomide | 67 | 2,224 | $171,045.04 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 57 | 2,869 | $871.04 | — |
| Kesimpta Pen | Ofatumumab | 49 | 1,438 | $453,489.80 | — |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | 1,470 | $636.16 | — |
| Dalfampridine Er | Dalfampridine | 29 | 870 | $4,485.64 | — |
| Vumerity | Diroximel Fumarate | 29 | 870 | $263,766.12 | — |
| Modafinil | Modafinil | 28 | 1,200 | $1,206.51 | — |
| Pregabalin | Pregabalin | 28 | 824 | $551.57 | — |
| Tizanidine Hcl | Tizanidine Hcl | 25 | 976 | $285.54 | — |
| Prednisone | Prednisone | 24 | 221 | $80.17 | 13 |
| Clonazepam | Clonazepam | 24 | 720 | $246.76 | — |
| Myrbetriq | Mirabegron | 24 | 722 | $10,798.63 | — |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | 810 | $146.86 | — |
| Dimethyl Fumarate | Dimethyl Fumarate | 23 | 690 | $3,699.24 | — |
| Cyclosporine | Cyclosporine | 22 | 330 | $4,445.54 | — |
| Methylphenidate Hcl | Methylphenidate Hcl | 21 | 870 | $437.25 | — |
| Ropinirole Hcl | Ropinirole Hcl | 20 | 1,080 | $318.05 | — |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 20 | 720 | $511.29 | — |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | 1,083 | $836.04 | — |
| Aubagio | Teriflunomide | 19 | 478 | $145,847.30 | — |
| Bafiertam | Monomethyl Fumarate | 19 | 633 | $136,226.57 | — |
| Donepezil Hcl | Donepezil Hcl | 18 | 1,200 | $92.39 | — |
| Meloxicam | Meloxicam | 17 | 690 | $31.22 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-08-08NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20181127001239
NE
6709120090
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner
Advanced Practice Registered Nurse
Clinical Nurse Specialist - Neuroscience
Advanced Practice Registered Nurse, Doctor of Philosophy (Ph.D.)
Nurse Practitioner
Advanced Practice Registered Nurse
Family Medicine
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Career & Practice History
NPI enumerated October 31, 2018.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from November 2018 to August 2026.
NPI Administrative Meta
Other Nurse Practitioners in Wahoo
Mailing Address
1760 County Road J
Wahoo, NE 680664152
Phone: 4024434191